Functional neuroimaging biomarkers of impaired neurocognition after proton beam radiotherapy for brain tumors in pediatric patients: A prospective trial
Neuro-Oncology · 30.03.2026
DOI: 10.1093/neuonc/noag072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 30.03.2026. Verfasst von Kathryn R Tringale und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine and Applied Science, University of California San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Proton Therapy, Functional Neuroimaging, Cognition Disorders. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Radiological Society of North America, UC San Diego Moores Cancer Center Cancer Center, Early-Stage Clinical Investigator.
Abstract (Originalsprache)
Background
Proton beam radiotherapy (PBRT) is a mainstay in treatment of pediatric brain tumors and may reduce risk of neurotoxicity. We hypothesized that dose-dependent effects on resting-state networks (RSNs) would manifest as impaired neurocognition and quality of life (QoL) in pediatric patients undergoing PBRT.
Methods
Patients and age- and sex-matched healthy controls (HCs) were prospectively enrolled and underwent resting-state functional connectivity (FC) MRI and neurocognitive tests (NIH Toolbox, PROMIS QoL Questionnaire) at 3-5 months post-PBRT. Functional connectivity within and between RSNs (default mode network [DMN], dorsal attention network [DAN], executive central network [ECN], salience network [SN]) was compared. One-sample t-tests assessed average RSN-specific FC. Group-level analysis used paired t-tests (q = 0.05).
Results
Twenty-eight participants (14 patients, 14 HCs; median age 14 years) were analyzed. Compared to HCs, patients displayed worse attention/executive function (P = .018), working memory (P = .011), and processing speed (P = .047). Patients had lower within-network FC in DMN (P = .013) and SN (P = .026). Patients had disrupted anticorrelation between DMN and SN, and less local efficiency of RSNs (corrected P < .05). Higher brain volume receiving ≥20 Gy, left hippocampus mean dose, and left temporal lobe mean dose were associated with RSN disruption in DMN and SN (|r|≥0.70). Lower SN FC was associated with poorer processing speed (P = .049). On multivariable analysis, ECN FC was associated with working memory (P = .016) and patients had worse working memory vs HCs (P = .009).
Conclusions
Compared to HCs, pediatric patients after PBRT displayed significant disruption in several RSNs, notably between SN and DMN critical in neurocognitive control. Dose-dependent neurocognition and QoL impairment warrant further investigation for mitigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Medicine and Applied Science, University of California San Diego, La Jolla, CA, USA.
- Rady Children's Hospital, San Diego, CA, USA.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- California Protons Cancer Therapy Center, San Diego, CA, USA.
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Kathryn R Tringale, Mehrnaz Jenabi, Jiwandeep Kohli, Christopher Jackson, Jona A Hattangadi-Gluth, Tara Fahy, Sameera Ramjan, Stephen Sands, Andrei Holodny, Behroze A Vachha
Förderung
- Radiological Society of North America
- UC San Diego Moores Cancer Center Cancer Center
- Early-Stage Clinical Investigator
- Memorial Sloan Kettering Cancer Center
- NIH
- NCI NIH HHS
- the Radiological Society of North America (RSNA) Resident Research
- UC San Diego Moores Cancer Center Cancer Center Support Grant Early-Stage Clinical Investigator Award partially supported time for analysis and manuscript deve…
Zitieren
APA
Tringale, K. R., Jenabi, M., Kohli, J., Jackson, C., Hattangadi-Gluth, J. A., McDonald, C. R., Fahy, T., Ramjan, S., Sands, S., Holodny, A., Wolden, S. L., & Vachha, B. A. (2026). Functional neuroimaging biomarkers of impaired neurocognition after proton beam radiotherapy for brain tumors in pediatric patients: A prospective trial. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag072
Vancouver
Tringale KR, Jenabi M, Kohli J, Jackson C, Hattangadi-Gluth JA, McDonald CR, et al. Functional neuroimaging biomarkers of impaired neurocognition after proton beam radiotherapy for brain tumors in pediatric patients: A prospective trial. Neuro-Oncology. 2026. doi:10.1093/neuonc/noag072
BibTeX
@article{Tringale2026,
author = {Tringale, Kathryn R and Jenabi, Mehrnaz and Kohli, Jiwandeep and Jackson, Christopher and Hattangadi-Gluth, Jona A and McDonald, Carrie R and Fahy, Tara and Ramjan, Sameera and Sands, Stephen and Holodny, Andrei and Wolden, Suzanne L and Vachha, Behroze A},
title = {Functional neuroimaging biomarkers of impaired neurocognition after proton beam radiotherapy for brain tumors in pediatric patients: A prospective trial},
journal = {Neuro-Oncology},
year = {2026},
doi = {10.1093/neuonc/noag072}
}
EUVIMED